Radius Health

RDUS NASDAQ
23.64
+1.64
+7.45%
盘后: 23.64 0 0.00% 16:48 06/17 EDT
开盘
22.28
昨收
22.00
最高
23.75
最低
22.03
成交量
64.10万
成交均量(3M)
54.54万
52周最高
31.92
52周最低
12.81
换手率
1.39%
市值
10.90亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Radius Health RDUS股票价格,Radius Health股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Radius Health, Inc. is a biopharmaceutical company. The Company is focused on the developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. The Company's lead investigational product candidate, TYMLOS (abaloparatide-SC) injection is developed for the treatment of postmenopausal women with osteoporosis at high risk for fracture. The Company’s clinical pipeline also includes an investigational abaloparatide transdermal patch for potential use in osteoporosis and the investigational drug elacestrant (RAD1901) for potential use in hormone-driven and/or hormone-resistant breast cancer, and vasomotor symptoms in postmenopausal women. Its RAD140 is a non-steroidal, selective androgen receptor modulator (SARM). RAD140 is under development for potential use in hormone receptor positive breast cancer.
展开 >

最近浏览

名称
价格
涨跌幅